Declared Dividend • Jul 13
Dividend increased to CN¥0.023 Dividend of CN¥0.023 is 9.5% higher than last year. Ex-date: 16th July 2026 Payment date: 16th July 2026 Dividend yield will be 0.2%, which is lower than the industry average of 2.6%. Payout Ratios Payout ratio: 11%. Cash payout ratio: 11%. Announcement • Jun 30
Cangzhou Dahua Co., Ltd. to Report First Half, 2026 Results on Aug 15, 2026 Cangzhou Dahua Co., Ltd. announced that they will report first half, 2026 results on Aug 15, 2026 Board Change • May 20
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Wenhu Zhang was the last independent director to join the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Announcement • Apr 24
Cangzhou Dahua Co., Ltd., Annual General Meeting, May 28, 2026 Cangzhou Dahua Co., Ltd., Annual General Meeting, May 28, 2026, at 10:30 China Standard Time. Location: The Company's Meeting Room, Cangzhou, Hebei China Announcement • Mar 30
Cangzhou Dahua Co., Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Cangzhou Dahua Co., Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Announcement • Dec 26
Cangzhou Dahua Co., Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Cangzhou Dahua Co., Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Announcement • Sep 30
Cangzhou Dahua Co., Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Cangzhou Dahua Co., Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Announcement • Jun 30
Cangzhou Dahua Co., Ltd. to Report First Half, 2025 Results on Aug 30, 2025 Cangzhou Dahua Co., Ltd. announced that they will report first half, 2025 results on Aug 30, 2025 Announcement • Apr 20
Cangzhou Dahua Co., Ltd., Annual General Meeting, May 28, 2025 Cangzhou Dahua Co., Ltd., Annual General Meeting, May 28, 2025, at 10:30 China Standard Time. Location: The Company's Meeting Room, Cangzhou, Hebei China Announcement • Mar 28
Cangzhou Dahua Co., Ltd. to Report Q1, 2025 Results on Apr 30, 2025 Cangzhou Dahua Co., Ltd. announced that they will report Q1, 2025 results on Apr 30, 2025 Announcement • Dec 27
Cangzhou Dahua Co., Ltd. to Report Fiscal Year 2024 Results on Apr 19, 2025 Cangzhou Dahua Co., Ltd. announced that they will report fiscal year 2024 results on Apr 19, 2025 New Risk • Oct 31
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 40% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by earnings (dividend per share is over 18x earnings per share). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.06% net profit margin). Reported Earnings • Oct 31
Third quarter 2024 earnings released: CN¥0.019 loss per share (vs CN¥0.21 profit in 3Q 2023) Third quarter 2024 results: CN¥0.019 loss per share (down from CN¥0.21 profit in 3Q 2023). Revenue: CN¥1.21b (down 15% from 3Q 2023). Net loss: CN¥7.91m (down 109% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥11.19, the stock trades at a trailing P/E ratio of 47.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 27% over the past three years. Announcement • Sep 30
Cangzhou Dahua Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Cangzhou Dahua Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Reported Earnings • Aug 31
Second quarter 2024 earnings released: EPS: CN¥0.021 (vs CN¥0.12 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.021 (down from CN¥0.12 in 2Q 2023). Revenue: CN¥1.31b (up 14% from 2Q 2023). Net income: CN¥8.86m (down 82% from 2Q 2023). Profit margin: 0.7% (down from 4.3% in 2Q 2023). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 20% per year, which means it is significantly lagging earnings. New Risk • Jul 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.4% average weekly change). Profit margins are more than 30% lower than last year (2.8% net profit margin). Announcement • Jun 28
Cangzhou Dahua Co., Ltd. to Report First Half, 2024 Results on Aug 31, 2024 Cangzhou Dahua Co., Ltd. announced that they will report first half, 2024 results on Aug 31, 2024 New Risk • May 08
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.8% Last year net profit margin: 7.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (2.8% net profit margin). Valuation Update With 7 Day Price Move • May 07
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥12.03, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 8.2% over the past three years. Announcement • Apr 30
Cangzhou Dahua Co., Ltd., Annual General Meeting, May 20, 2024 Cangzhou Dahua Co., Ltd., Annual General Meeting, May 20, 2024, at 10:30 China Standard Time. Location: The Company's Meeting Room, Cangzhou, Hebei China Announcement • Mar 30
Cangzhou Dahua Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024 Cangzhou Dahua Co., Ltd. announced that they will report Q1, 2024 results on Apr 29, 2024 Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥10.34, the stock trades at a trailing P/E ratio of 9.8x. Average trailing P/E is 28x in the Chemicals industry in China. Total returns to shareholders of 6.0% over the past three years. Announcement • Dec 29
Cangzhou Dahua Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Cangzhou Dahua Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 Reported Earnings • Nov 01
Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.078 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.21 (up from CN¥0.078 in 3Q 2022). Revenue: CN¥1.42b (up 15% from 3Q 2022). Net income: CN¥87.3m (up 169% from 3Q 2022). Profit margin: 6.1% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Announcement • Sep 30
Cangzhou Dahua Co., Ltd. to Report Q3, 2023 Results on Oct 28, 2023 Cangzhou Dahua Co., Ltd. announced that they will report Q3, 2023 results at 3:00 PM, China Standard Time on Oct 28, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.15 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.12 (down from CN¥0.15 in 2Q 2022). Revenue: CN¥1.15b (down 9.5% from 2Q 2022). Net income: CN¥49.6m (down 20% from 2Q 2022). Profit margin: 4.3% (down from 4.9% in 2Q 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 28
Full year 2022 earnings released: EPS: CN¥1.02 (vs CN¥0.54 in FY 2021) Full year 2022 results: EPS: CN¥1.02 (up from CN¥0.54 in FY 2021). Revenue: CN¥4.91b (up 106% from FY 2021). Net income: CN¥420.1m (up 91% from FY 2021). Profit margin: 8.5% (down from 9.2% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Changqing Li was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.078 (vs CN¥0.047 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.078 (up from CN¥0.047 in 3Q 2021). Revenue: CN¥1.23b (up 139% from 3Q 2021). Net income: CN¥32.4m (up 65% from 3Q 2021). Profit margin: 2.6% (down from 3.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Oct 17
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥24.89, the stock trades at a trailing P/E ratio of 50.9x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 119% over the past three years. Valuation Update With 7 Day Price Move • Oct 03
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥20.09, the stock trades at a trailing P/E ratio of 41.1x. Average trailing P/E is 25x in the Chemicals industry in China. Total returns to shareholders of 77% over the past three years. Reported Earnings • Aug 19
Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.20 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.20 in 2Q 2021). Revenue: CN¥1.27b (up 105% from 2Q 2021). Net income: CN¥61.7m (down 27% from 2Q 2021). Profit margin: 4.9% (down from 14% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥16.84, the stock trades at a trailing P/E ratio of 30.9x. Average trailing P/E is 30x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years. Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment improved over the past week After last week's 20% share price gain to CN¥18.10, the stock trades at a trailing P/E ratio of 33.2x. Average trailing P/E is 27x in the Chemicals industry in China. Total returns to shareholders of 31% over the past three years. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment deteriorated over the past week After last week's 20% share price decline to CN¥12.65, the stock trades at a trailing P/E ratio of 24x. Average trailing P/E is 23x in the Chemicals industry in China. Total loss to shareholders of 29% over the past three years. Reported Earnings • Apr 27
Full year 2021 earnings released: EPS: CN¥0.54 (vs CN¥0.09 in FY 2020) Full year 2021 results: EPS: CN¥0.54 (up from CN¥0.09 in FY 2020). Revenue: CN¥2.39b (up 44% from FY 2020). Net income: CN¥220.3m (up 496% from FY 2020). Profit margin: 9.2% (up from 2.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 4 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥16.91, the stock trades at a trailing P/E ratio of 17.6x. Average trailing P/E is 31x in the Chemicals industry in China. Total returns to shareholders of 4.1% over the past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.047 (vs CN¥0.015 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥517.1m (up 3.8% from 3Q 2020). Net income: CN¥19.7m (up CN¥25.8m from 3Q 2020). Profit margin: 3.8% (up from net loss in 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment deteriorated over the past week After last week's 20% share price decline to CN¥17.20, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 31x in the Chemicals industry in China. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Sep 14
Investor sentiment improved over the past week After last week's 18% share price gain to CN¥21.78, the stock trades at a trailing P/E ratio of 24x. Average trailing P/E is 33x in the Chemicals industry in China. Negligible returns to shareholders over past three years. Reported Earnings • Aug 05
Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.31 loss in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥618.7m (up 63% from 2Q 2020). Net income: CN¥85.0m (up CN¥212.2m from 2Q 2020). Profit margin: 14% (up from net loss in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 89 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jul 10
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥13.62, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS CN¥0.09 (vs CN¥0.11 in FY 2019) The company reported a poor full year result with weaker earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥1.65b (down 22% from FY 2019). Net income: CN¥36.9m (down 19% from FY 2019). Profit margin: 2.2% (in line with FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Is New 90 Day High Low • Feb 27
New 90-day high: CN¥15.38 The company is up 54% from its price of CN¥9.96 on 27 November 2020. The Chinese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Is New 90 Day High Low • Feb 09
New 90-day high: CN¥11.78 The company is up 21% from its price of CN¥9.71 on 11 November 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Jan 08
New 90-day low: CN¥8.60 The company is down 16% from its price of CN¥10.19 on 09 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 15% over the same period. Is New 90 Day High Low • Dec 24
New 90-day low: CN¥8.85 The company is down 13% from its price of CN¥10.18 on 25 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total losses of CN¥174.5m, with earnings decreasing by CN¥186.6m from the prior year. Total revenue was CN¥1.57b over the last 12 months, down 37% from the prior year. Is New 90 Day High Low • Oct 26
New 90-day low: CN¥9.44 The company is down 8.0% from its price of CN¥10.21 on 28 July 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 7.0% over the same period.